Published in Health Qual Life Outcomes on March 31, 2009
Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database. Health Qual Life Outcomes (2013) 1.27
Mapping onto Eq-5 D for patients in poor health. Health Qual Life Outcomes (2010) 1.20
Should linking replace regression when mapping from profile-based measures to preference-based measures? Value Health (2014) 0.98
Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients. Health Qual Life Outcomes (2012) 0.93
A comparison of health-related quality of life (health utility) between insulin degludec and insulin glargine: a meta-analysis of phase 3 trials. Diabetes Obes Metab (2013) 0.90
Are social security policies for Chinese landless farmers really effective on health in the process of Chinese rapid urbanization? A study on the effect of social security policies for Chinese landless farmers on their health-related quality of life. Int J Equity Health (2014) 0.87
A brief patient-reported outcome instrument for primary care: German translation and validation of the Measure Yourself Medical Outcome Profile (MYMOP). Health Qual Life Outcomes (2014) 0.82
Deriving a mapping algorithm for converting SF-36 scores to EQ-5D utility score in a Korean population. Health Qual Life Outcomes (2014) 0.80
Effect of Exposure to Second-Hand Smoke on the Quality of Life: A Nationwide Population-Based Study from South Korea. PLoS One (2015) 0.80
Mapping FACT-P to EQ-5D in a large cross-sectional study of metastatic castration-resistant prostate cancer patients. Qual Life Res (2014) 0.79
Mapping and direct valuation: do they give equivalent EQ-5D-5L index scores? Health Qual Life Outcomes (2015) 0.78
Mapping Functions in Health-Related Quality of Life: Mapping from Two Cancer-Specific Health-Related Quality-of-Life Instruments to EQ-5D-3L. Med Decis Making (2015) 0.78
Methods for network meta-analysis of continuous outcomes using individual patient data: a case study in acupuncture for chronic pain. BMC Med Res Methodol (2016) 0.78
From KIDSCREEN-10 to CHU9D: creating a unique mapping algorithm for application in economic evaluation. Health Qual Life Outcomes (2014) 0.78
Estimation of utility values from visual analog scale measures of health in patients undergoing cardiac surgery. Clinicoecon Outcomes Res (2014) 0.78
Predicting preference-based utility values using partial proportional odds models. BMC Res Notes (2014) 0.77
The impact of different health dimensions on overall quality of life related to kyphoplasty and non-surgical management. Osteoporos Int (2013) 0.77
Assessing the external validity of algorithms to estimate EQ-5D-3L from the WOMAC. Health Qual Life Outcomes (2016) 0.76
Mapping the neck disability index to SF-6D in patients with chronic neck pain. Health Qual Life Outcomes (2016) 0.76
Using quality-adjusted progression-free survival as an outcome measure to assess the benefits of cancer drugs in randomized-controlled trials: case of the BOLERO-2 trial. Breast Cancer Res Treat (2014) 0.76
Measuring quality of life in opioid-induced constipation: mapping EQ-5D-3 L and PAC-QOL. Health Econ Rev (2016) 0.76
Cost-effectiveness of adjunct non-pharmacological interventions for osteoarthritis of the knee. PLoS One (2017) 0.75
Mapping of Multiple Sclerosis Walking Scale (MSWS-12) to five-dimension EuroQol (EQ-5D) health outcomes: an independent validation in a randomized control cohort. Patient Relat Outcome Meas (2016) 0.75
Mapping the EQ-5D index from the cystic fibrosis questionnaire-revised using multiple modelling approaches. Health Qual Life Outcomes (2015) 0.75
The clinical and cost effectiveness of group art therapy for people with non-psychotic mental health disorders: a systematic review and cost-effectiveness analysis. BMC Psychiatry (2015) 0.75
Utility scores for different health states related to depression: individual participant data analysis. Qual Life Res (2017) 0.75
Longitudinal predictive ability of mapping models: examining post-intervention EQ-5D utilities derived from baseline MHAQ data in rheumatoid arthritis patients. Eur J Health Econ (2012) 0.75
Modeling valuations for EuroQol health states. Med Care (1997) 21.66
The estimation of a preference-based measure of health from the SF-36. J Health Econ (2002) 14.18
US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care (2005) 9.89
Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care (2002) 6.63
A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ (2004) 4.42
Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol (1998) 3.57
Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample. Med Decis Making (2006) 2.09
Estimating the association between SF-12 responses and EQ-5D utility values by response mapping. Med Decis Making (2006) 1.89
Mapping the SF-12 to the EuroQol EQ-5D Index in a national US sample. Med Decis Making (2004) 1.75
Deriving an algorithm to convert the eight mean SF-36 dimension scores into a mean EQ-5D preference-based score from published studies (where patient level data are not available). Value Health (2008) 1.64
Predicting EuroQoL EQ-5D preference scores from the SF-12 Health Survey in a nationally representative sample. Med Decis Making (2004) 1.58
NICE Guide to the Methods of Technology Appraisal: pharmaceutical industry perspective. Pharmacoeconomics (2008) 1.55
The routine collation of health outcomes data from hospital treated subjects in the Health Outcomes Data Repository (HODaR): descriptive analysis from the first 20,000 subjects. Value Health (2005) 1.11
The estimation of a preference-based measure of health from the SF-36. J Health Econ (2002) 14.18
The estimation of a preference-based measure of health from the SF-12. Med Care (2004) 7.25
Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol (2012) 6.05
A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ (2004) 4.42
Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice. Mol Ther (2008) 2.69
Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence. J Health Serv Res Policy (2007) 2.66
Efficiency, equity, and NICE clinical guidelines. BMJ (2004) 2.55
Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ (2005) 2.52
Activation of the signal transducers and activators of the transcription 3 pathway in alveolar epithelial cells induces inflammation and adenocarcinomas in mouse lung. Cancer Res (2007) 2.04
Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV/AIDS. Med Decis Making (2002) 1.94
The use of standard contracts in the English National Health Service: a case study analysis. Soc Sci Med (2011) 1.80
Deriving an algorithm to convert the eight mean SF-36 dimension scores into a mean EQ-5D preference-based score from published studies (where patient level data are not available). Value Health (2008) 1.64
Cost-effectiveness of an improving access to psychological therapies service. Br J Psychiatry (2013) 1.63
The impact of HIV and AIDS on Africa's economic development. BMJ (2002) 1.62
Using rank data to estimate health state utility models. J Health Econ (2006) 1.53
Modelling valuations for Eq-5d health states: an alternative model using differences in valuations. Med Care (2002) 1.49
Continuing the multiple sclerosis risk sharing scheme is unjustified. BMJ (2010) 1.48
Tailored psychotherapy for patients with functional neurological symptoms: a pilot study. J Psychosom Res (2007) 1.46
Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study. J Bone Miner Res (2007) 1.45
Modelling SF-6D health state preference data using a nonparametric Bayesian method. J Health Econ (2006) 1.40
How valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? A systematic review. Value Health (2011) 1.37
Canadian valuation of EQ-5D health states: preliminary value set and considerations for future valuation studies. PLoS One (2012) 1.31
A review of generic preference-based measures of health-related quality of life in visual disorders. Value Health (2011) 1.24
Using a discrete choice experiment to estimate health state utility values. J Health Econ (2011) 1.22
Deriving a preference-based measure for cancer using the EORTC QLQ-C30. Value Health (2011) 1.20
Using the health assessment questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis. Arthritis Rheum (2007) 1.19
Estimating a preference-based single index from the Overactive Bladder Questionnaire. Value Health (2008) 1.18
To what extent can we explain time trade-off values from other information about respondents? Soc Sci Med (2002) 1.17
Stat3 downstream genes serve as biomarkers in human lung carcinomas and chronic obstructive pulmonary disease. Lung Cancer (2008) 1.17
Exercising choice: the economic determinants of physical activity behaviour of an employed population. Soc Sci Med (2011) 1.16
Health-state utility values in breast cancer. Expert Rev Pharmacoecon Outcomes Res (2010) 1.16
Estimation of a preference-based index from a condition-specific measure: the King's Health Questionnaire. Med Decis Making (2007) 1.16
Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets. J Health Econ (2005) 1.16
An endogenous TNF-alpha antagonist induced by splice-switching oligonucleotides reduces inflammation in hepatitis and arthritis mouse models. Mol Ther (2008) 1.15
A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index. Health Econ (2003) 1.10
Quality of life of people with mental health problems: a synthesis of qualitative research. Health Qual Life Outcomes (2012) 1.09
An investigation of the construct validity of the ICECAP-A capability measure. Qual Life Res (2012) 1.07
Using DCE and ranking data to estimate cardinal values for health states for deriving a preference-based single index from the sexual quality of life questionnaire. Health Econ (2009) 1.06
Valuation of the SF-6D Health States Is Feasible, Acceptable, Reliable, and Valid in a Chinese Population. Value Health (2008) 1.05
Is the EQ-5D fit for purpose in mental health? Br J Psychiatry (2010) 1.04
Valuing Child Health Utility 9D health states with a young adolescent sample: a feasibility study to compare best-worst scaling discrete-choice experiment, standard gamble and time trade-off methods. Appl Health Econ Health Policy (2011) 1.03
Discriminative capacity of the EQ-5D, SF-6D, and SF-12 as measures of health status in population health survey. Qual Life Res (2010) 1.03
Dietary acrylamide does not increase colon aberrant crypt foci formation in male F344 rats. Food Chem Toxicol (2011) 1.02
How bad is depression? Preference score estimates from depressed patients and the general population. Health Serv Res (2009) 1.01
Predicting the short form-6D preference-based index using the eight mean short form-36 health dimension scores: estimating preference-based health-related utilities when patient level data are not available. Value Health (2008) 1.00
Preference-based condition-specific measures of health: what happens to cross programme comparability? Health Econ (2010) 0.98
It's all in the name, or is it? The impact of labeling on health state values. Med Decis Making (2011) 0.97
Effect of adding a sleep dimension to the EQ-5D descriptive system: a "bolt-on" experiment. Med Decis Making (2013) 0.97
Does the EQ-5D reflect lost earnings? Pharmacoeconomics (2012) 0.96
Developing adolescent-specific health state values for economic evaluation: an application of profile case best-worst scaling to the Child Health Utility 9D. Pharmacoeconomics (2012) 0.96
Valuing condition-specific health states using simulation contact lenses. Value Health (2011) 0.96
Design and performance of a multi-centre randomised controlled trial and economic evaluation of joint tele-consultations [ISRCTN54264250]. BMC Fam Pract (2002) 0.96
A comparison of patient and general population weightings of EQ-5D dimensions. Health Econ (2009) 0.94
An Australian discrete choice experiment to value eq-5d health states. Health Econ (2013) 0.94
In or out? Income losses in health state valuations: a review. Value Health (2009) 0.93
Mechanism of the Escherichia coli DNA T:G-mismatch endonuclease (Vsr protein) probed with thiophosphate-containing oligodeoxynucleotides. J Mol Biol (2005) 0.93
The importance of Bcl-xL in the survival of human RPE cells. Invest Ophthalmol Vis Sci (2007) 0.93
Health state values for the HUI 2 descriptive system: results from a UK survey. Health Econ (2005) 0.92
Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review. BMC Ophthalmol (2013) 0.92
Valuing states from multiple measures on the same visual analogue sale: a feasibility study. Health Econ (2011) 0.91
The longitudinal course of PTSD among disaster workers deployed to the World Trade Center following the attacks of September 11th. J Trauma Stress (2011) 0.91
Estimation of utilities in attention-deficit hyperactivity disorder for economic evaluations. Patient (2011) 0.90
The archaeal XPB protein is a ssDNA-dependent ATPase with a novel partner. J Mol Biol (2007) 0.90
Comparison of generic, condition-specific, and mapped health state utility values for multiple myeloma cancer. Value Health (2012) 0.90
Discounting and cost-effectiveness in NICE - stepping back to sort out a confusion. Health Econ (2006) 0.90
Estrogen receptor-β mediates the inhibition of DLD-1 human colon adenocarcinoma cells by soy isoflavones. Nutr Cancer (2011) 0.89
An assessment of the construct validity of the CHU9D in the Australian adolescent general population. Qual Life Res (2011) 0.89
Valuing the EQ-5D and the SF-6D health states using subjective well-being: a secondary analysis of patient data. Soc Sci Med (2012) 0.89
The Study of the Prevention of Anal Cancer (SPANC): design and methods of a three-year prospective cohort study. BMC Public Health (2013) 0.89
A stated preference binary choice experiment to explore NICE decision making. Pharmacoeconomics (2007) 0.89
What value health?: A review of health state values used in early technology assessments for NICE. Appl Health Econ Health Policy (2005) 0.88
Quality of life and illness costs in irritable bowel syndrome. Digestion (2004) 0.88
FKBPL and peptide derivatives: novel biological agents that inhibit angiogenesis by a CD44-dependent mechanism. Clin Cancer Res (2011) 0.88
Comparing EQ-5D scores for comorbid health conditions estimated using 5 different methods. Med Care (2012) 0.87
Monitoring outcomes for the Medicare Advantage program: methods and application of the VR-12 for evaluation of plans. J Ambul Care Manage (2012) 0.87
Binary choice health state valuation and mode of administration: head-to-head comparison of online and CAPI. Value Health (2013) 0.86
Estimating a preference-based index from the Japanese SF-36. J Clin Epidemiol (2009) 0.86
A clinical and economic evaluation of fast-track recovery after cardiac surgery. Heart Surg Forum (2011) 0.86
A preference-based measure of health: the VR-6D derived from the veterans RAND 12-Item Health Survey. Qual Life Res (2011) 0.85
Prevalence and predictors of posttraumatic stress symptoms in utility workers deployed to the World Trade Center following the attacks of September 11, 2001. Depress Anxiety (2010) 0.85
Exploring the factors contributing to sibling correlations in BMI: a study using the Panel Study of Income Dynamics. Obesity (Silver Spring) (2011) 0.85
An assessment of validity and responsiveness of generic measures of health-related quality of life in hearing impairment. Qual Life Res (2013) 0.84
Acute stress disorder after burn injury: a predictor of posttraumatic stress disorder? Psychosom Med (2002) 0.83
Implementing a reward and reminder underage drinking prevention program in convenience stores near Southern California American Indian reservations. Am J Drug Alcohol Abuse (2012) 0.83
Estimating health state utility values for comorbid health conditions using SF-6D data. Value Health (2011) 0.83
A pilot Internet "value of health" panel: recruitment, participation and compliance. Health Qual Life Outcomes (2006) 0.82
Liquid-based versus conventional cervical cytology. Lancet (2006) 0.81
Estimating a preference-based index for a menopause specific health quality of life questionnaire. Health Qual Life Outcomes (2005) 0.81
Lifestyle Matters for maintenance of health and wellbeing in people aged 65 years and over: study protocol for a randomised controlled trial. Trials (2013) 0.81
Measurement of utility values in the UK for health states related to immune thrombocytopenic purpura. Curr Med Res Opin (2010) 0.81
How to measure quality of life for cost-effectiveness analyses of personality disorders: a systematic review. J Pers Disord (2013) 0.81
Understanding the effect of disease adaptation information on general population values for hypothetical health states. Soc Sci Med (2011) 0.81
Growth hormone receptor (GHR) gene polymorphism and Prader-Willi syndrome. Am J Med Genet A (2013) 0.80
Multi-attribute utility function or statistical inference models: a comparison of health state valuation models using the HUI2 health state classification system. J Health Econ (2007) 0.80
Whose values in health? An empirical comparison of the application of adolescent and adult values for the CHU-9D and AQOL-6D in the Australian adolescent general population. Value Health (2012) 0.79